Evidence map›Paper›PMID 29264167›Full record

ReviewAsian journal of urology2016

Advances in prostate cancer research models: From transgenic mice to tumor xenografting models.

Yuejiao Huang, Chun Cheng, Chong Zhang, Yonghui Zhang, Miaomiao Chen, Douglas W Strand, Ming Jiang

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Asian journal of urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yuejiao HuangDepartment of Oncology, Affiliated Cancer Hospital of Nantong University, Nantong, Jiangsu, China.
Chun ChengDepartment of Immunology, Nantong University School of Medicine, Nantong, Jiangsu, China.
Chong ZhangLaboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong, Jiangsu, China.
Yonghui ZhangLaboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong, Jiangsu, China.
Miaomiao ChenLaboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong, Jiangsu, China.
Douglas W StrandDepartment of Urology, UT Southernwestern Medical Center, Dallas, TX, USA.
Ming JiangLaboratory of Nuclear Receptors and Cancer Research, Center for Basic Medical Research, Nantong University School of Medicine, Nantong, Jiangsu, China.
Nantong University · CNUniversity of Tennessee Southern · US

Funding

Mechanisms of Fatty Acid Metabolism in Prostate Differentiation and DiseaseK01DK098277 · NIDDK · VANDERBILT UNIVERSITY · PI STRAND, DOUGLAS WILLIAM · 2013 to 2017
$640k
NIDDK NIH HHS K01 DK098277
6 · The paper itself

Abstract

The identification of the origin and molecular characteristics of prostate cancer (PCa) has crucial implications for personalized treatment. The development of effective treatments for PCa has been limited; however, the recent establishment of several transgenic mouse lines and/or xenografting models is better reflecting the disease

Indexed as

Prostate cancerTransgenic mouse linesTranslational medical systemsTumor xenografting models

Identifiers

PMID29264167
PMCPMC5730804
OpenAlexW2288619329

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.